<!DOCTYPE html><!--WLCgvrrdknkKZDhW_WCbK--><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="preload" href="/search/_next/static/media/47cbc4e2adbc5db9-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="stylesheet" href="/search/_next/static/css/e446a64f2ff89daf.css" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="/search/_next/static/js/webpack.ccaf2443.js"/><script src="/search/_next/static/js/4bd1b696.100b9d70.js" async=""></script><script src="/search/_next/static/js/1255.90e9842b.js" async=""></script><script src="/search/_next/static/js/main-app.0e7376d5.js" async=""></script><script src="/search/_next/static/js/9692.83f9877c.js" async=""></script><script src="/search/_next/static/js/421.98ca62d9.js" async=""></script><script src="/search/_next/static/js/1759.b13f3ee1.js" async=""></script><script src="/search/_next/static/js/3535.878ceef2.js" async=""></script><script src="/search/_next/static/js/2619.b8db57ac.js" async=""></script><script src="/search/_next/static/js/3820.af314958.js" async=""></script><script src="/search/_next/static/js/574.fd20103e.js" async=""></script><script src="/search/_next/static/js/5738.d28a9943.js" async=""></script><script src="/search/_next/static/js/app/layout.7ef30b9e.js" async=""></script><script src="/search/_next/static/js/690.e023e61b.js" async=""></script><script src="/search/_next/static/js/5332.4ca3e6c6.js" async=""></script><script src="/search/_next/static/js/2410.ec36c5aa.js" async=""></script><script src="/search/_next/static/js/5183.9f1a7545.js" async=""></script><script src="/search/_next/static/js/3055.8a1757af.js" async=""></script><script src="/search/_next/static/js/8977.d520dad7.js" async=""></script><script src="/search/_next/static/js/app/items/%5Bslug%5D/page.0819d17d.js" async=""></script><meta name="next-size-adjust" content=""/><meta name="emotion-insertion-point" content=""/><link rel="preconnect" href="https://fonts.googleapis.com"/><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin="anonymous"/><link rel="preconnect" href="https://www.cataloguementalhealth.ac.uk"/><link rel="dns-prefetch" href="https://harmonydata.ac.uk"/><title>The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey</title><meta name="description" content="This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for."/><meta property="og:title" content="The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey"/><meta property="og:description" content="This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for."/><meta property="og:url" content="https://harmonydata.ac.uk/search/items/social-and-ethical-implications-of-genetic-screening-part-1-spinal-muscular-atrophy-screening-survey"/><meta property="og:site_name" content="Academic Resource Discovery"/><meta property="og:locale" content="en_US"/><meta property="og:image" content="https://harmonydata.ac.uk/search/harmony.png"/><meta property="og:image:width" content="1200"/><meta property="og:image:height" content="630"/><meta property="og:image:alt" content="The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey"/><meta name="twitter:description" content="This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for."/><meta name="twitter:image" content="https://harmonydata.ac.uk/search/harmony.png"/><link rel="icon" href="/search/favicon.ico" type="image/x-icon" sizes="16x16"/><style>
            /* Ensure immediate rendering with Roboto and fallbacks */
            * { 
              font-family: "Roboto", -apple-system, BlinkMacSystemFont, "Segoe UI", "Oxygen", "Ubuntu", "Cantarell", "Fira Sans", "Droid Sans", "Helvetica Neue", sans-serif !important;
              font-display: swap;
              -webkit-font-smoothing: antialiased;
              -moz-osx-font-smoothing: grayscale;
            }
            body { 
              visibility: visible !important; 
              opacity: 1 !important; 
              margin: 0; 
              padding: 0; 
            }
          </style><script src="/search/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule=""></script><style data-emotion="mui-global v658lt">html{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;box-sizing:border-box;-webkit-text-size-adjust:100%;}*,*::before,*::after{box-sizing:inherit;}strong,b{font-weight:700;}body{margin:0;color:#1A1A1A;font-size:0.875rem;line-height:1.5;font-family:'Roboto','Roboto Fallback',-apple-system,BlinkMacSystemFont,Segoe UI,Oxygen,Ubuntu,Cantarell,Fira Sans,Droid Sans,Helvetica Neue,sans-serif;font-weight:400;background-color:#FFFFFF;}@media (min-width:600px){body{font-size:1rem;}}@media print{body{background-color:#fff;}}body::backdrop{background-color:#FFFFFF;}</style></head><body><div hidden=""><!--$--><!--/$--></div><!--$!--><template data-dgst="BAILOUT_TO_CLIENT_SIDE_RENDERING"></template><div>Loading...</div><!--/$--><script src="/search/_next/static/js/webpack.ccaf2443.js" id="_R_" async=""></script><script>(self.__next_f=self.__next_f||[]).push([0])</script><script>self.__next_f.push([1,"1:\"$Sreact.fragment\"\n2:I[52332,[\"9692\",\"static/js/9692.83f9877c.js\",\"421\",\"static/js/421.98ca62d9.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"2619\",\"static/js/2619.b8db57ac.js\",\"3820\",\"static/js/3820.af314958.js\",\"574\",\"static/js/574.fd20103e.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"7177\",\"static/js/app/layout.7ef30b9e.js\"],\"default\"]\n3:I[65380,[\"9692\",\"static/js/9692.83f9877c.js\",\"421\",\"static/js/421.98ca62d9.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"2619\",\"static/js/2619.b8db57ac.js\",\"3820\",\"static/js/3820.af314958.js\",\"574\",\"static/js/574.fd20103e.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"7177\",\"static/js/app/layout.7ef30b9e.js\"],\"AuthProvider\"]\n4:I[41627,[\"9692\",\"static/js/9692.83f9877c.js\",\"421\",\"static/js/421.98ca62d9.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"2619\",\"static/js/2619.b8db57ac.js\",\"3820\",\"static/js/3820.af314958.js\",\"574\",\"static/js/574.fd20103e.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"7177\",\"static/js/app/layout.7ef30b9e.js\"],\"FirebaseProvider\"]\n5:\"$Sreact.suspense\"\n6:I[92114,[\"9692\",\"static/js/9692.83f9877c.js\",\"421\",\"static/js/421.98ca62d9.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"2619\",\"static/js/2619.b8db57ac.js\",\"3820\",\"static/js/3820.af314958.js\",\"574\",\"static/js/574.fd20103e.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"7177\",\"static/js/app/layout.7ef30b9e.js\"],\"SearchProvider\"]\n7:I[94049,[\"9692\",\"static/js/9692.83f9877c.js\",\"421\",\"static/js/421.98ca62d9.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"2619\",\"static/js/2619.b8db57ac.js\",\"3820\",\"static/js/3820.af314958.js\",\"574\",\"static/js/574.fd20103e.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"7177\",\"static/js/app/layout.7ef30b9e.js\"],\"default\"]\n8:I[20190,[\"9692\",\"static/js/9692.83f9877c.js\",\"421\",\"static/js/421.98ca62d9.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"2619\",\"static/js/2619.b8db57ac.js\",\"3820\",\"static/js/3820.af314958.js\",\"574\",\"static/j"])</script><script>self.__next_f.push([1,"s/574.fd20103e.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"7177\",\"static/js/app/layout.7ef30b9e.js\"],\"default\"]\n9:I[9766,[],\"\"]\na:I[98924,[],\"\"]\nb:I[74744,[\"9692\",\"static/js/9692.83f9877c.js\",\"421\",\"static/js/421.98ca62d9.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"2619\",\"static/js/2619.b8db57ac.js\",\"3820\",\"static/js/3820.af314958.js\",\"574\",\"static/js/574.fd20103e.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"7177\",\"static/js/app/layout.7ef30b9e.js\"],\"ToastContainer\"]\nd:I[24431,[],\"OutletBoundary\"]\nf:I[15278,[],\"AsyncMetadataOutlet\"]\n11:I[24431,[],\"ViewportBoundary\"]\n13:I[24431,[],\"MetadataBoundary\"]\n15:I[57150,[],\"\"]\n:HL[\"/search/_next/static/media/47cbc4e2adbc5db9-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n:HL[\"/search/_next/static/css/e446a64f2ff89daf.css\",\"style\"]\n"])</script><script>self.__next_f.push([1,"0:{\"P\":null,\"b\":\"WLCgvrrdknkKZDhW-WCbK\",\"p\":\"/search\",\"c\":[\"\",\"items\",\"social-and-ethical-implications-of-genetic-screening-part-1-spinal-muscular-atrophy-screening-survey\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"items\",{\"children\":[[\"slug\",\"social-and-ethical-implications-of-genetic-screening-part-1-spinal-muscular-atrophy-screening-survey\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/search/_next/static/css/e446a64f2ff89daf.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}]],[\"$\",\"html\",null,{\"lang\":\"en\",\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"meta\",null,{\"name\":\"emotion-insertion-point\",\"content\":\"\"}],[\"$\",\"link\",null,{\"rel\":\"preconnect\",\"href\":\"https://fonts.googleapis.com\"}],[\"$\",\"link\",null,{\"rel\":\"preconnect\",\"href\":\"https://fonts.gstatic.com\",\"crossOrigin\":\"anonymous\"}],[\"$\",\"link\",null,{\"rel\":\"preconnect\",\"href\":\"https://www.cataloguementalhealth.ac.uk\"}],[\"$\",\"link\",null,{\"rel\":\"dns-prefetch\",\"href\":\"https://harmonydata.ac.uk\"}],[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"\\n            /* Ensure immediate rendering with Roboto and fallbacks */\\n            * { \\n              font-family: \\\"Roboto\\\", -apple-system, BlinkMacSystemFont, \\\"Segoe UI\\\", \\\"Oxygen\\\", \\\"Ubuntu\\\", \\\"Cantarell\\\", \\\"Fira Sans\\\", \\\"Droid Sans\\\", \\\"Helvetica Neue\\\", sans-serif !important;\\n              font-display: swap;\\n              -webkit-font-smoothing: antialiased;\\n              -moz-osx-font-smoothing: grayscale;\\n            }\\n            body { \\n              visibility: visible !important; \\n              opacity: 1 !important; \\n              margin: 0; \\n              padding: 0; \\n            }\\n          \"}}]]}],[\"$\",\"body\",null,{\"children\":[\"$\",\"$L2\",null,{\"children\":[\"$\",\"$L3\",null,{\"children\":[\"$\",\"$L4\",null,{\"children\":[\"$\",\"$5\",null,{\"fallback\":[\"$\",\"div\",null,{\"children\":\"Loading...\"}],\"children\":[\"$\",\"$L6\",null,{\"children\":[[\"$\",\"$L7\",null,{\"sx\":{\"display\":\"flex\",\"flexDirection\":{\"xs\":\"column\",\"md\":\"row\"}},\"children\":[[\"$\",\"$L8\",null,{}],[\"$\",\"$L7\",null,{\"component\":\"main\",\"sx\":{\"flexGrow\":1,\"ml\":{\"xs\":0,\"md\":\"72px\"},\"mt\":{\"xs\":\"64px\",\"md\":0},\"minHeight\":{\"xs\":\"calc(100vh - 64px)\",\"md\":\"100vh\"},\"width\":{\"xs\":\"100%\",\"md\":\"calc(100% - 72px)\"}},\"children\":[\"$\",\"$L9\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$La\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[[\"$\",\"title\",null,{\"children\":\"404: This page could not be found.\"}],[\"$\",\"div\",null,{\"style\":{\"fontFamily\":\"system-ui,\\\"Segoe UI\\\",Roboto,Helvetica,Arial,sans-serif,\\\"Apple Color Emoji\\\",\\\"Segoe UI Emoji\\\"\",\"height\":\"100vh\",\"textAlign\":\"center\",\"display\":\"flex\",\"flexDirection\":\"column\",\"alignItems\":\"center\",\"justifyContent\":\"center\"},\"children\":[\"$\",\"div\",null,{\"children\":[[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}\"}}],[\"$\",\"h1\",null,{\"className\":\"next-error-h1\",\"style\":{\"display\":\"inline-block\",\"margin\":\"0 20px 0 0\",\"padding\":\"0 23px 0 0\",\"fontSize\":24,\"fontWeight\":500,\"verticalAlign\":\"top\",\"lineHeight\":\"49px\"},\"children\":404}],[\"$\",\"div\",null,{\"style\":{\"display\":\"inline-block\"},\"children\":[\"$\",\"h2\",null,{\"style\":{\"fontSize\":14,\"fontWeight\":400,\"lineHeight\":\"49px\",\"margin\":0},\"children\":\"This page could not be found.\"}]}]]}]}]],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]}]]}],[\"$\",\"$Lb\",null,{\"position\":\"bottom-right\"}]]}]}]}]}]}]}]]}]]}],{\"children\":[\"items\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L9\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$La\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"social-and-ethical-implications-of-genetic-screening-part-1-spinal-muscular-atrophy-screening-survey\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L9\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$La\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$Lc\",null,[\"$\",\"$Ld\",null,{\"children\":[\"$Le\",[\"$\",\"$Lf\",null,{\"promise\":\"$@10\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$L11\",null,{\"children\":\"$L12\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$L13\",null,{\"children\":\"$L14\"}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$15\",[]],\"s\":false,\"S\":true}\n"])</script><script>self.__next_f.push([1,"14:[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$5\",null,{\"fallback\":null,\"children\":\"$L16\"}]}]\n"])</script><script>self.__next_f.push([1,"17:I[41402,[\"9692\",\"static/js/9692.83f9877c.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"690\",\"static/js/690.e023e61b.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"5332\",\"static/js/5332.4ca3e6c6.js\",\"2410\",\"static/js/2410.ec36c5aa.js\",\"5183\",\"static/js/5183.9f1a7545.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"3055\",\"static/js/3055.8a1757af.js\",\"8977\",\"static/js/8977.d520dad7.js\",\"6387\",\"static/js/app/items/%5Bslug%5D/page.0819d17d.js\"],\"\"]\n19:I[78977,[\"9692\",\"static/js/9692.83f9877c.js\",\"1759\",\"static/js/1759.b13f3ee1.js\",\"690\",\"static/js/690.e023e61b.js\",\"3535\",\"static/js/3535.878ceef2.js\",\"5332\",\"static/js/5332.4ca3e6c6.js\",\"2410\",\"static/js/2410.ec36c5aa.js\",\"5183\",\"static/js/5183.9f1a7545.js\",\"5738\",\"static/js/5738.d28a9943.js\",\"3055\",\"static/js/3055.8a1757af.js\",\"8977\",\"static/js/8977.d520dad7.js\",\"6387\",\"static/js/app/items/%5Bslug%5D/page.0819d17d.js\"],\"default\"]\n18:T78f,"])</script><script>self.__next_f.push([1,"{\"@context\":\"https://schema.org/\",\"@type\":\"Dataset\",\"name\":\"The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey\",\"description\":\"This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for.\",\"url\":\"https://harmonydata.ac.uk/search/items/social-and-ethical-implications-of-genetic-screening-part-1-spinal-muscular-atrophy-screening-survey\",\"identifier\":[\"http://dx.doi.org/10.5255/UKDA-SN-852600\"],\"keywords\":[\"SPINAL MUSCULAR ATROPHY\",\"GENETIC SCREENING\",\"DISABILITY\",\"REPROGENETICS\",\"ETHICS\",\"ATTITUDES\"],\"temporalCoverage\":\"2014-09-01/2015-06-30\"}"])</script><script>self.__next_f.push([1,"1a:T56f,"])</script><script>self.__next_f.push([1,"This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for."])</script><script>self.__next_f.push([1,"c:[\"$\",\"$5\",null,{\"fallback\":[\"$\",\"div\",null,{\"children\":\"Loading...\"}],\"children\":[[\"$\",\"$L17\",null,{\"strategy\":\"beforeInteractive\",\"id\":\"structured-data\",\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"$18\"}}],[\"$\",\"$L19\",null,{\"study\":{\"dataset_schema\":{\"@context\":\"https://schema.org/\",\"@type\":\"Dataset\",\"name\":\"The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey\",\"description\":\"$1a\",\"url\":[\"https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=852600\",\"https://reshare.ukdataservice.ac.uk/852600\"],\"keywords\":[\"SPINAL MUSCULAR ATROPHY\",\"GENETIC SCREENING\",\"DISABILITY\",\"REPROGENETICS\",\"ETHICS\",\"ATTITUDES\"],\"identifier\":[\"http://dx.doi.org/10.5255/UKDA-SN-852600\"],\"includedInDataCatalog\":[{\"@type\":\"DataCatalog\",\"name\":\"UK Data Service\",\"url\":\"https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=852600\"}],\"sponsor\":[{\"@type\":\"Organization\",\"name\":\"Economic and Social Research Council\"}],\"temporalCoverage\":\"2014-09-01/2015-06-30\"},\"extra_data\":{\"duration_years\":1,\"start_year\":2014,\"harmony_id\":\"ukds/852600\",\"end_year\":2015,\"data_access\":\"The Data Collection is available for download to users registered with the UK Data Service.\",\"urls\":[\"https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=852600\",\"https://reshare.ukdataservice.ac.uk/852600\"],\"name\":\"The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey\",\"geographic_coverage\":\"\",\"genetic_data_collected\":true,\"slug\":\"social-and-ethical-implications-of-genetic-screening-part-1-spinal-muscular-atrophy-screening-survey\",\"dois\":[\"http://dx.doi.org/10.5255/UKDA-SN-852600\"],\"sex\":\"male\",\"instruments\":[],\"study_design\":[\"survey\"],\"ai_summary\":null,\"country_codes\":[\"GB\"],\"language_codes\":[\"en\"],\"num_variables\":null,\"source\":[\"ukds\"],\"resource_type\":\"dataset\",\"uuid\":\"15547fd69908a7eb732d22c6684a8e20\"},\"distance\":0,\"score\":0,\"parent\":{},\"ancestors\":[]}}]]}]\n"])</script><script>self.__next_f.push([1,"12:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}]]\ne:null\n"])</script><script>self.__next_f.push([1,"1b:T56f,"])</script><script>self.__next_f.push([1,"This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for."])</script><script>self.__next_f.push([1,"1c:T56f,"])</script><script>self.__next_f.push([1,"This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for."])</script><script>self.__next_f.push([1,"10:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"$1b\"}],[\"$\",\"meta\",\"2\",{\"property\":\"og:title\",\"content\":\"The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey\"}],[\"$\",\"meta\",\"3\",{\"property\":\"og:description\",\"content\":\"$1c\"}],[\"$\",\"meta\",\"4\",{\"property\":\"og:url\",\"content\":\"https://harmonydata.ac.uk/search/items/social-and-ethical-implications-of-genetic-screening-part-1-spinal-muscular-atrophy-screening-survey\"}],\"$L1d\",\"$L1e\",\"$L1f\",\"$L20\",\"$L21\",\"$L22\",\"$L23\",\"$L24\",\"$L25\",\"$L26\",\"$L27\",\"$L28\",\"$L29\"],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script>self.__next_f.push([1,"2b:I[80622,[],\"IconMark\"]\n1d:[\"$\",\"meta\",\"5\",{\"property\":\"og:site_name\",\"content\":\"Academic Resource Discovery\"}]\n1e:[\"$\",\"meta\",\"6\",{\"property\":\"og:locale\",\"content\":\"en_US\"}]\n1f:[\"$\",\"meta\",\"7\",{\"property\":\"og:image\",\"content\":\"https://harmonydata.ac.uk/search/harmony.png\"}]\n20:[\"$\",\"meta\",\"8\",{\"property\":\"og:image:width\",\"content\":\"1200\"}]\n21:[\"$\",\"meta\",\"9\",{\"property\":\"og:image:height\",\"content\":\"630\"}]\n22:[\"$\",\"meta\",\"10\",{\"property\":\"og:image:alt\",\"content\":\"The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey\"}]\n23:[\"$\",\"meta\",\"11\",{\"property\":\"og:type\",\"content\":\"website\"}]\n24:[\"$\",\"meta\",\"12\",{\"name\":\"twitter:card\",\"content\":\"summary_large_image\"}]\n25:[\"$\",\"meta\",\"13\",{\"name\":\"twitter:title\",\"content\":\"The social and ethical implications of genetic screening - Part 1: Spinal muscular atrophy screening survey\"}]\n2a:T56f,"])</script><script>self.__next_f.push([1,"This data file contains the responses of 337 participants who completed the SMA Screening Survey (UK). All participants live with Spinal Muscular Atrophy in some capacity (either having it themselves or having it in their family). Participants were asked about their views towards population genetic screening: pre-conception genetic screening, prenatal genetic screening and newborn genetic screening. They were also asked about their previous use of reproductive genetic technologies and their views on the wider issue of pregnancy termination. Data collection occurred between September 2014 and June 2015. A related data collection consisting of interview transcripts is also made available (see Related Resources). This study explores the social and ethical implications of the potential introduction of genetic screening for conditions with variable presentations and focusing on the condition Spinal Muscular Atrophy (SMA). The study aims to explore what families living with SMA think about genetic screening and testing in order to understand the role and value of direct ‘experiential knowledge’ in reproductive decision-making. The study also aims to explore whether families living with genetic disease approach screening decisions in a different way to pregnant women from the general population without such ‘experiential knowledge’ of the condition being screened for."])</script><script>self.__next_f.push([1,"26:[\"$\",\"meta\",\"14\",{\"name\":\"twitter:description\",\"content\":\"$2a\"}]\n27:[\"$\",\"meta\",\"15\",{\"name\":\"twitter:image\",\"content\":\"https://harmonydata.ac.uk/search/harmony.png\"}]\n28:[\"$\",\"link\",\"16\",{\"rel\":\"icon\",\"href\":\"/search/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}]\n29:[\"$\",\"$L2b\",\"17\",{}]\n16:\"$10:metadata\"\n"])</script></body></html>